by The Bacillus Coagulans market comprises of dietary supplements containing Bacillus Coagulans bacteria, which provides several health benefits like supporting digestive health, immune function, weight management and more. Bacillus Coagulans is a naturally-occurring, spore-forming bacteria found in the gastrointestinal tract and fermented foods. Dietary supplements with Bacillus Coagulans deliver billions of active bacterial spores to the gut, where they germinate and proliferate in the intestines.
The global Bacillus Coagulans market size is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030.
Market key trends:
One of the major trends in the Bacillus Coagulans market is the growing demand for probiotic supplements for gut health and immune support. There is increasing consumer awareness about the link between gut microbiota, overall well-being and disease risk. Several clinical studies have demonstrated the positive effects of Bacillus Coagulans in maintaining digestive regularity, relieving certain gastrointestinal issues like diarrhea and abdominal pain. The rising prevalence of irritable bowel syndrome and other digestive disorders is driving growth of probiotic supplements containing Bacillus Coagulans. Manufacturers are developing innovative product formats like gummies and chewable tablets targeting specific consumer segments like kids and elderly. New research exploring additional health benefits of Bacillus Coagulans like weight management and immune function optimization is further expanding its market potential.
Porter’s Analysis
Threat of new entrants: The Bacillus Coagulans Market has moderate threat from new entrants due to significant capital requirements for R&D and manufacturing operations.
Bargaining power of buyers: The bargaining power of buyers in the market is moderate as the buyers have some alternate options available.
Bargaining power of suppliers: There are many suppliers in the market providing raw materials for Bacillus Coagulans Market thus giving them less bargaining power.
Threat of new substitutes: Substitutes present low threat as Bacillus Coagulans provides distinct health benefits that are difficult to substitute.
Competitive rivalry: The Bacillus Coagulans Market witnesses high competitive rivalry among existing players leading to pricing pressures.
Key Takeaways
The global Bacillus Coagulans market is expected to witness high growth over the forecast period of 2023 to 2030. The global Bacillus Coagulans market size is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030.
North America dominates the Bacillus Coagulans market due to increasing health consciousness. The market in Asia Pacific is expected to witness the fastest growth rate during the forecast period with India and China being the major contributors to the region’s growth.
Key players operating in the Bacillus Coagulans market are BASF SE (Germany), Dow (U.S.), CLARIANT (Switzerland), Nippon Paint Holdings Co., Ltd.(Japan), PPG Industries, Inc. (U.S.), The Sherwin-Williams Company (U.S.), Huntsman International LLC. (U.S.), MarvelVinyls (India), The VersaFlex Companies (U.S.), Axalta Coating Systems, LLC (U.S.), Pidilite Industries Ltd. (India), Valspar (U.S.), Rhino Linings Corporation. (U.S.), Nukote Coating Systems, Intl. (U.S.), Jotun (Norway), RODDA PAINT, CO. (U.S.), Constro Chem India Pvt. Ltd. (India), ELMET (U.S.), Aalberts Surface Technologies GmbH.(Netherlands).
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
